Top Markets
Coin of the day
ERYTECH Pharma S.A. ERYTECH Pharma S.A.

ERYTECH Pharma S.A.

ERYP
Pozycja w akcjach #24699
ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on... ERYTECH Pharma S.A. is a clinical-stage biopharmaceutical company focused on creating innovative therapies derived from red blood cells. These treatments target various types of cancer and rare (orphan) diseases, with the company operating in both France and the United States. Its primary experimental drug, eryaspase, is currently undergoing Phase 3 clinical trials for patients battling second-line pancreatic cancer. Furthermore, this candidate is also in Phase 2 development for triple-negative breast cancer and for individuals with second-line acute lymphoblastic leukemia. The company is additionally advancing erymethionase, a preclinical-stage product. This candidate utilizes methionine-gamma-lyase, encased within red blood cells, to specifically address cancers that are dependent on methionine for growth. Established in 2004, ERYTECH Pharma's corporate headquarters are situated in Lyon, France.
Cena akcji
$0.95011029
Ostatnia synchronizacja: 2023-06-28
Kapitalizacja rynkowa
$57.72M
Zmiana (1 dzień)
8.53%
Zmiana (1 rok)
0.00%
Kraj
FR
Handel ERYTECH Pharma S.A. (ERYP)

Kategoria

Historia ceny akcji dla ERYTECH Pharma S.A. (ERYP)
Najwyższa cena zamknięcia: $0.90 dnia 2023-06-01

Najniższa cena zamknięcia: $14.08 dnia 2013-05-01
Historia cen akcji firmy ERYTECH Pharma S.A. od 2013 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2023 73.43%
2022 -78.67%
2021 -73.09%
2020 82.31%
2019 -31.19%
2018 -67.04%
2017 59.44%
2016 -51.05%
2015 -15.86%
2014 158.90%
2013 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$550.69 38.55%
US
$1.05K 58.44%
NL
$149.06 468.48%
US
$118.70 -18.24%
AU
$770.19 9.84%
CH